We studied a panel of eight MB cell lines in this study (Fig. 1A, Table 1), reflecting three main medulloblastoma subgroups (SHH, Group 3 and Group 4) and of varying MYC and p53 mutational status. The gene discussed is TP53; the disease is medulloblastoma.